Amin M. Alousi
0000-0002-2498-8573
Publication & Citation Trends
Publications
0 total
Donor Characteristics Significantly Impact the Composition of Peripheral Blood Stem Cell Grafts
Cited by 0
Semantic Scholar
Myeloablative Fractionated Busulfan, Fludarabine, Cladribine, Thiotepa, and Venetoclax (Cladillac) Conditioning for High-Risk AML: A Phase 2 Trial
Cited by 0
Semantic Scholar
Reduced relapse in high risk acute myeloid leukemia and myelodysplastic neoplasms with permissive HLA-DPB1 mismatches and post-transplant cyclophosphamide.
Cited by 0
Semantic Scholar
Adverse Impact of MMF in AML/MDS Patients with High HCT-CI Receiving Matched Allogeneic Stem Cell Transplantation with PTCy-Based GvHD Prophylaxis
Cited by 0
Semantic Scholar
Acalabrutinib for Treatment of Steroid-Refractory Chronic Graft Vs. Host Disease: Primary Trial Results
Cited by 0
Semantic Scholar
Fecal carbohydrate-degrading bacteria are associated with reduced incidence of lower gastrointestinal GVHD
Cited by 0
Semantic Scholar
Persistent Symptom Burden and Unmet Needs in Long-Term Survivors of Allogeneic Hematopoietic Cell Transplantation: An Analysis Using the MD Anderson Symptom Inventory (MDASI-BMT)
Cited by 0
Semantic Scholar
A Phase 2 Trial of Myeloablative Fractionated Busulfan, Fludarabine, Cladribine, Thiotepa, and Venetoclax (Cladillac) Conditioning for High-Risk MDS
Cited by 0
Semantic Scholar
Research Topics
Hematopoietic Stem Cell Transplantation
(337)
Acute Myeloid Leukemia Research
(185)
Acute Lymphoblastic Leukemia research
(147)
Chronic Myeloid Leukemia Treatments
(104)
Lymphoma Diagnosis and Treatment
(76)
Affiliations
Liechtenstein Institute
Boston Children's Hospital
Dalhousie University
Apple (Israel)
Hudson Institute